FAP and metabolic syndrome: In pathological tissues, elevated expression of FAP-α is typically detrimental; thus, inhibiting FAP-α is considered beneficial for the treatment of inflammatory diseases such as metabolic syndrome, cancer, and fibrosis [24,25].